©The Author(s) 2025.
World J Clin Oncol. Nov 24, 2025; 16(11): 112030
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112030
Published online Nov 24, 2025. doi: 10.5306/wjco.v16.i11.112030
Table 3 Characteristics of pancreatic lesions on magnetic resonance imaging and endoscopic ultrasound, n (%)
| MRI (n = 40) | EUS (n = 231) | P value | |
| Cystic lesion | 35 (87.5) | 182 (78.8) | 0.203 |
| Size (mm) | 6.4 ± 2.2 | 6.2 ± 5.0 | 0.503 |
| Number | |||
| 1 | 21 | 171 | < 0.001 |
| 2 | 7 | 6 | |
| 3 | 4 | 3 | |
| ≥ 4 | 3 | 2 | |
| Solid lesion | 5 (12.5) | 42 (18.2) | 0.381 |
| Size (mm) | 18.0 ± 11.8 | 9.2 ± 6.9 | 0.044 |
| Number | |||
| 1 | 5 | 41 | 0.727 |
| 2 | 0 | 1 | |
| Cystic and solid lesion | 0 (0) | 7 (3.0) | 0.265 |
- Citation: Lin WC, Yu LY, Kuo YC, Chang CW, Wang HY, Shih SC, Chang CW, Lin HH, Chan YH, Lin YC, Hu KC. Role of endoscopic ultrasonography or magnetic resonance imaging for screening of pancreatic cancer in low-risk individuals. World J Clin Oncol 2025; 16(11): 112030
- URL: https://www.wjgnet.com/2218-4333/full/v16/i11/112030.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i11.112030